4.6 Article

E2F and Ras Synergize in Transcriptionally Activating p14(ARF) Expression

Journal

CELL CYCLE
Volume 2, Issue 2, Pages 127-133

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cc.2.2.293

Keywords

p14(ARF); E2F; Ras; Oncogenic stimuli; Transcriptional regulation; Sp-1

Categories

Funding

  1. Israel Cancer Association (ICA)
  2. Minerva Foundation (Germany)
  3. Israel Cancer Research Fund (ICRF)
  4. Yad Abraham Research Center for Diagnostics and Therapy

Ask authors/readers for more resources

The INK4a/ARF locus, which is frequently inactivated in human tumors, encodes two distinct tumor suppressive proteins, ARF and p16(INK4a). ARF stabilizes and activates p53 by negating the effects of mdm2 on p53. Furthermore, its function is not restricted to the p53 pathway and it also inhibits cell proliferation in cells lacking p53. Expression of ARF is up-regulated in response to a number of oncogenic stimuli including E2F1. We show here that while oncogenic Ras does not significantly affect p14(ARF) expression in normal human cells it activates p14(ARF) in cells containing deregulated E2F. Moreover, oncogenic Ras and E2F1 synergize in activating p14(ARF) expression. Activation of p14(ARF) promoter by E2F1 persists in the absence of the consensus E2F-binding sites in this promoter, indicating that this activation also occurs through non- canonical binding sites. The activation by oncogenic Ras requires both E2F and Sp-1 activity, demonstrating the complex regulation of p14(ARF) in response to oncogenic stimuli.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available